Press Release

Morgan Lewis Advises Formula Pharmaceuticals on Merger with CoImmune

May 04, 2020

PHILADELPHIA, May 4, 2020: Morgan Lewis represented Formula Pharmaceuticals Inc. in its merger with CoImmune Inc.

Formula is a privately held biopharmaceutical company developing a proprietary, next-generation chimeric antigen receptor (CAR) immunotherapy platform. CoImmune specializes in the development of personalized immuno-oncology therapies

Partners Jeff Bodle and Joanne Soslow and associate Conor Larkin represented Formula.

For more, read CoImmune’s announcement.